The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.5M data for 737K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

13 articles for MJ Lohse


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
2-Alkynyl derivatives of adenosine and adenosine-5'-N-ethyluronamide as selective agonists at A2 adenosine receptors.EBI
University of Camerino
Adenosine receptor agonists: synthesis and biological evaluation of 1-deaza analogues of adenosine derivatives.EBI
University of Camerino
FRET-based sensors for the human M1-, M3-, and M5-acetylcholine receptors.EBI
University of Wuerzburg
A Versatile Sub-Nanomolar Fluorescent Ligand Enables NanoBRET Binding Studies and Single-Molecule Microscopy at the Histamine HEBI
University of Regensburg
Conformational cross-talk between alpha2A-adrenergic and mu-opioid receptors controls cell signaling.EBI
Massachusetts General Hospital
Structure-Activity Relationships and Computational Investigations into the Development of Potent and Balanced Dual-Acting Butyrylcholinesterase Inhibitors and Human Cannabinoid Receptor 2 Ligands with Pro-Cognitive in Vivo Profiles.EBI
Julius Maximilian University of W£Rzburg
Inhibitors of human 12/15-lipoxygenaseBDB
The Children'S Hospital
Chemokine CXCR1 and CXCR2 receptor antagonist compounds, and use thereof in the treatment of chemokine-mediated pathologiesBDB
Galderma Research & Development
Compounds for treatment of fibrosis diseasesBDB
Curegenix
Structure-based design and combinatorial chemistry yield low nanomolar inhibitors of cathepsin D.BDB
University of California Berkeley
Conformationally constrained farnesoid X receptor (FXR) agonists: Naphthoic acid-based analogs of GW 4064.BDB
Gsk
Inhibitor Scaffolds for 2-Oxoglutarate-Dependent Histone Lysine Demethylases.BDB
University of Oxford